BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wan J, Imadojemu S, Werth VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum. Clinics in Dermatology 2016;34:344-52. [DOI: 10.1016/j.clindermatol.2016.02.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Griger Z, Nagy-Vincze M, Dankó K. Pharmacological management of dermatomyositis. Expert Rev Clin Pharmacol 2017;10:1109-18. [PMID: 28691537 DOI: 10.1080/17512433.2017.1353910] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Scott RE, Greenwood SL, Hayes DJL, Baker BC, Jones RL, Heazell AEP. Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review. Reprod Toxicol 2019;87:50-9. [PMID: 31082466 DOI: 10.1016/j.reprotox.2019.05.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Arese V, Murabito P, Ribero S, Panzone M, Tonella L, Fierro MT, Papini M, Quaglino P. Autoimmune connective tissue diseases and pregnancy. G Ital Dermatol Venereol 2019;154:263-76. [PMID: 30650958 DOI: 10.23736/S0392-0488.18.06252-1] [Reference Citation Analysis]
4 Patsatsi A, Marinovic B, Murrell D. Autoimmune bullous diseases during pregnancy: Solving common and uncommon issues. Int J Womens Dermatol 2019;5:166-70. [PMID: 31360750 DOI: 10.1016/j.ijwd.2019.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Cozzani E, Cioni M, Gariazzo L, Burlando M, Parodi A. The management of autoimmune diseases in preconception, pregnancy and lactation. G Ital Dermatol Venereol. 2019;154:299-304. [PMID: 30375218 DOI: 10.23736/s0392-0488.18.06212-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Akiyama C, Shirai T, Sato H, Fujii H, Ishii T, Harigae H. Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy. Rheumatol Int 2021. [PMID: 33837447 DOI: 10.1007/s00296-021-04851-1] [Reference Citation Analysis]
7 Fernandez AP. Updated recommendations on the use of hydroxychloroquine in dermatologic practice. J Am Acad Dermatol 2017;76:1176-82. [PMID: 28318681 DOI: 10.1016/j.jaad.2017.01.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
8 Fagundes PPS, Santi CG, Maruta CW, Miyamoto D, Aoki V. Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach. An Bras Dermatol 2021:S0365-0596(21)00170-7. [PMID: 34304937 DOI: 10.1016/j.abd.2020.10.007] [Reference Citation Analysis]
9 Kushner CJ, Concha JSS, Werth VP. Treatment of Autoimmune Bullous Disorders in Pregnancy. Am J Clin Dermatol 2018;19:391-403. [DOI: 10.1007/s40257-018-0342-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
10 Barsotti S, Lundberg IE. Current Treatment for Myositis. Curr Treatm Opt Rheumatol 2018;4:299-315. [PMID: 30613465 DOI: 10.1007/s40674-018-0106-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]